Hyperglycemia Treatment Market Information: By Treatment (Fluid Replacement, Electrolyte Replacement, Insulin Therapy, Drugs), Mode of Administration (Topical, Oral), End User (Hospitals & Clinics, Retail Pharmacy) - Global Forecast till 2027Market HighlightsHyperglycemia is a disorder caused by increased blood glucose (blood sugar) level.
Hyperglycemia is a sign of diabetes including both type 1 diabetes and type 2 diabetes.
According to the World Health Organization, nearly 60 million people have diabetes in the European region and the prevalence is relatively high in age group over 25 years.
It is mainly caused by obesity, unhealthy diet, and physical inactivity, which indirectly increase the market growth.
However, high cost of the treatment may slow the market growth during the period 2017-2023.The global hyperglycemia treatment market is expected to grow at a CAGR of 9.8 % during the forecast period 2017-2023.Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/4565 SegmentationThe global hyperglycemia treatment market has been segmented on the basis of treatment, mode of administration and end user.On the basis of treatment, it is segmented into fluid replacement, electrolyte replacement, insulin therapy, and drugs.
Europe holds the second largest share of the global hyperglycemia treatment market as result of increasing focus of various government agencies on the treatment of hyperglycemia and cardiovascular diseases.